Michael Fehlings - Concepedia

Author

Michael Fehlings

Also Known As

Clifford Librach, Fehlings, Michael, Karlo M. Pedro, M. Fehlings, Michael Fehlings, Michael G. Fehlings, Michael G. Fehlings (142465), Michael G. Fehlings

Publications

3.7K

Citations

H-Index

Concepts

All Affiliations

Singapore Immunology Network Fred Hutch Cancer Center Agency for Science, Technology and Research Johns Hopkins Medicine National Institute of Allergy and Infectious Diseases

About

Michael Fehlings is an author at Singapore Immunology Network specializing in medicine, immunology, and autoimmunity.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	2.4K
2	Immunology	10	10	2.4K
3	Cell Biology	4	4	1.9K
4	Allergy	1	1	274
5	Microbiology	1	1	60

Michael Fehlings

Publications

Citations

H-Index

Page 1

	Year	Citations
Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates Yannick Simoni, Étienne Becht, Michael Fehlings, Nature Cancer ImmunosurveillanceImmunologyTumor ImmunityHuman Tumour InfiltratesImmunoediting	2018	1.3K
High-Dimensional Analysis Delineates Myeloid and Lymphoid Compartment Remodeling during Successful Immune-Checkpoint Cancer Therapy Matthew M. Gubin, Ekaterina Esaulova, Jeffrey P. Ward, Cell Tumor BiologyLymphoid NeoplasiaMedicineMalignant Blood DisorderImmunology	2018	407
SARS-CoV-2–specific CD8+ T cell responses in convalescent COVID-19 individuals Hassen Kared, Andrew D. Redd, Evan M. Bloch, Journal of Clinical Investigation AllergyT CellsCovid-19 PandemicImmunologyAntigen Processing	2021	274
Hepatocellular Carcinoma Cells Up-regulate PVRL1, Stabilizing PVR and Inhibiting the Cytotoxic T-Cell Response via TIGIT to Mediate Tumor Resistance to PD1 Inhibitors in Mice David Kung‐Chun Chiu, Vincent Wai‐Hin Yuen, Jacinth Wing‐Sum Cheu, Gastroenterology Mediate Tumor ResistanceImmunologyPd1 InhibitorsImmune Checkpoint InhibitorStabilizing Pvr	2020	159
Tissue-resident-like CD4+ T cells secreting IL-17 control Mycobacterium tuberculosis in the human lung Paul Ogongo, Liku B. Tezera, Amanda Ardain, Journal of Clinical Investigation	2021	123
CD8+ T-Cell Responses in COVID-19 Convalescent Individuals Target Conserved Epitopes From Multiple Prominent SARS-CoV-2 Circulating Variants Andrew D. Redd, Alessandra Nardin, Hassen Kared, Open Forum Infectious Diseases Coronavirus Disease 2019Viral EvolutionCd8+ T-cell ResponsesAdaptive Immune SystemCovid-19 Pandemic	2021	107
Minimal Crossover between Mutations Associated with Omicron Variant of SARS-CoV-2 and CD8 <sup>+</sup> T-Cell Epitopes Identified in COVID-19 Convalescent Individuals Andrew D. Redd, Alessandra Nardin, Hassen Kared, mBio	2022	86
Late-differentiated effector neoantigen-specific CD8+ T cells are enriched in peripheral blood of non-small cell lung carcinoma patients responding to atezolizumab treatment Michael Fehlings, Suchit Jhunjhunwala, Marcin Kowanetz, Journal for ImmunoTherapy of Cancer	2019	83
A Subset of Type I Conventional Dendritic Cells Controls Cutaneous Bacterial Infections through VEGFα-Mediated Recruitment of Neutrophils Baptiste Janela, Amit A. Patel, Mai Chan Lau, Immunity InflammationBacterial InfectionsMicrobial DiseaseMicrobial PathogensGranulocyte	2019	60
NY-ESO-1-specific redirected T cells with endogenous TCR knockdown mediate tumor response and cytokine release syndrome Mikiya Ishihara, Shigehisa Kitano, Shinichi Kageyama, Journal for ImmunoTherapy of Cancer	2022	56

Page 1